Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02877771 · ClinicalTrials.gov registry record · Phase 1
Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study
A Phase 1 study, sponsored by Tandem Diabetes Care.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT02877771 is a Phase 1 study that has completed, run by Tandem Diabetes Care. The registered enrollment target is 10 participants.
The verdict
NCT02877771, a Phase 1 study, has completed, sponsored by Tandem Diabetes Care.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal of this study is to assess the functionality of an integrated predictive low glucose suspend system designed to minimize the incidence and duration of hypoglycemia by suspending insulin delivery if hypoglycemia is projected.
Interventions
- DEVICE t:slim insulin pump with predictive low glucose suspend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-08 |
| Est. Completion | 2016-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02877771
The ClinicalTrials.gov registry entry for NCT02877771 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tandem Diabetes Care, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which t:slim insulin pump with predictive low glucose suspend is the first listed.
NCT02877771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02877771 about?
NCT02877771 is a clinical study titled "Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study". The goal of this study is to assess the functionality of an integrated predictive low glucose suspend system designed to minimize the incidence and duration of hypoglycemia by suspending insulin delivery if hypoglycemia is projected.
What is the current status of trial NCT02877771?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2016-08. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02877771?
The interventions under investigation include: t:slim insulin pump with predictive low glucose suspend (DEVICE).
Who is sponsoring clinical trial NCT02877771?
This trial is sponsored by Tandem Diabetes Care, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.